GSK

#News for #Media and #Investors: Today we announced interim positive headline results from our phase II trial evaluating one of our immuno-oncology therapies. Learn more: gsk.to/4vZVG6L

#News for #Investors and #Media: Today, our licensor Hansoh Pharma announced data on an investigational antibody-drug conjugate in our oncology pipeline for cancers with high unmet needs. Learn more: gsk.to/44X0o9i

@301ninja Hello, we're again sorry to hear about your experience. Please share your contact information and reference ID with us in a direct message so we can forward your concerns to the relevant team. Thank you.

@GSK I did a while back and nothing happened so I'm making it public. My manager didn't do anything about it besides get frustrated with me and say that we handle matters like that in house. The person that did it got promoted. It's b.s. and it was at your Rockville md site.

@GSK what should happen if an employee hits another employee while they are changing in the locker room?

@ShikhaVerm28360 Thank you for reaching out with your concerns about the authenticity of your product. To help us investigate this for you, please email our team at askus@gsk.com with as many details as you can. Thanks for your support.

Looks like I received fake medicated body lotion. QR code is not scannable. I ordered from Netmed. @NetMeds @MoHFW_INDIA @GSK

#News for #Media and #Investors: The FDA has approved our oral anti-infective for complicated urinary tract infections (cUTIs). With three million cUTIs treated annually in the US, this approval reflects our commitment to innovation in anti-infectives. Learn more: gsk.to/4aBCpje

#News for #Investors and #Media: Today, we announced that the US FDA and the EMA have granted regulatory designations for one of our therapies for the treatment of VEXAS syndrome. Learn more: gsk.to/4vJGgCT

#News for #investors and #media: Following today’s agreement to acquire Nuvalent, Inc., our CEO Luke Miels shares why this acquisition is strategically important to our oncology business as we continue to strengthen our pipeline and commitment to patients. Read more from Luke in our press release: gsk.to/4gaudKr

#News for #investors and #media: We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio. Find out more: gsk.to/4ooHOjy

#News for #investors & #media: Today at #EASLCongress, we’re presenting results from a phase III trial in chronic hepatitis B, a disease affecting approximately 240 million people globally. Thank you to everyone involved who made this research possible. 🔗 Learn more: gsk.to/3Q8X47g

#News for #investors and #media: We're excited to be at #ASCO26 and #EHA2026, where we will share data on how we're delivering a meaningful impact for cancer patients today while innovating for tomorrow. Learn more: gsk.to/4wPL9f1

#News for #Investors and #Media: Today, we are announcing that one of our vaccines has been approved for an expanded population by the Japanese Ministry of Health, Labour and Welfare (MHLW). Learn more: gsk.to/3PKzP3i

@NwachukwuColl18 Thank you for reaching out with your concerns. To help us look into this further, please email our team at counterfeits@gsk.com with as many details as possible. We appreciate your time and support.

@GSK please, confirm, augmentin, amoxicillin+ clavulanate potassium 625 mg, batch number SD3L produced April 2024, if it is authentic for consumption. Thanks

At #ATS2026, we're sharing findings from 33 research projects across our portfolio of inhaled therapies and biologics – reflecting our ambitious treatment goals, moving beyond symptom control to transform outcomes for people living with chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Our innovation is driving new treatment approaches including long-acting therapies, which aim to redefine care and alleviate the significant burden on patients and health systems worldwide. We believe advancing research is one of the most meaningful investments we can make for a healthier future.

@kanandsingh09 Hello Anand. Sensodyne is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, haleon.com/contact-us/. Sorry we couldn't be of help this time.

@GSK Hello team I am propriter of bluemdix bazar samiti ara bihar (india) To notify you,i have been not getting any sensodyne paste from Bhojpur Emporium shiv ganj ara. Even after contious follow ups. The behaviour is unethical and very rude Take necessary action against them

Thanks for bringing this to our attention. We’re very sorry to hear about your experience. We want to assure you that patient safety and product quality are our highest priorities, and we take all such matters very seriously. To ensure this is thoroughly investigated, please contact our GSK India team directly at askus@gsk.com. They are best placed to gather all the necessary details and provide you with support. Thank you for your time.

Bought a fresh strip of Augmentin recently and found a defective tablet with visible holes inside. Packaging and expiry were fine, yet the tablet looked abnormal. Medicines are about health and trust — quality control cannot be compromised. #PatientSafety #Pharma

@surenban Crocin is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, haleon.com/contact-us/. Sorry we couldn't be of help this time.

@GSK is it Cronin 650 or 500? @MoHFW_INDIA - what your drug controller is doing?

@Poetic_Hubble33 Hello. Panadol is now made by Haleon, not GSK. We encourage you to reach out with further feedback or questions via their channel @Haleon_health or their website, haleon.com/contact-us/. Sorry we couldn't be of help this time.

@NadimMa40539410 Hi Mahmudul, thanks for reaching out. We'd love to help but industry regulations mean we're not able to discuss our medicines with you. Your doctor or healthcare professional will be best placed to support. We hope this helps.

@GSK What is latest update About Bepirovirsen Medicine?

#News for #investors and #media: At #ATS2026, we’ll be presenting data across 33 abstracts to highlight our research as we work to redefine respiratory care. gsk.to/42ejQxd

@A_Shandilya23 Hi Ankit, thanks for getting in touch. Otrivin is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, haleon.com/contact-us/. Sorry we couldn't be of help this time.

@GSK Have you stopped making Otrivin P nasal drops??